These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

176 related items for PubMed ID: 16598104

  • 1. Use of the TandemHeart percutaneous ventricular assist device to support patients undergoing high-risk percutaneous coronary intervention.
    Kar B, Forrester M, Gemmato C, Civitello A, Loyalka P, Myers T, Reynolds D.
    J Invasive Cardiol; 2006 Mar; 18(3):93-6. PubMed ID: 16598104
    [Abstract] [Full Text] [Related]

  • 2. Use of the TandemHeart Percutaneous Ventricular Assist Device to Support Patients Undergoing High-Risk Percutaneous Coronary Intervention.
    Kar B, Forrester M, Gemmato C, Civitello A, Loyalka P, Myers T, Delgado R.
    J Invasive Cardiol; 2006 Apr; 18(4):A6. PubMed ID: 16732059
    [Abstract] [Full Text] [Related]

  • 3. Single-center experience with the TandemHeart percutaneous ventricular assist device to support patients undergoing high-risk percutaneous coronary intervention.
    Al-Husami W, Yturralde F, Mohanty G, Pastore C, Lotun K, Venesy D, Waxman S, Pyne C, Gossman D, Nesto R, Piemonte T.
    J Invasive Cardiol; 2008 Jun; 20(6):319-22. PubMed ID: 18523330
    [Abstract] [Full Text] [Related]

  • 4. Percutaneous left ventricular assist device with TandemHeart for high-risk percutaneous coronary intervention: the Mayo Clinic experience.
    Alli OO, Singh IM, Holmes DR, Pulido JN, Park SJ, Rihal CS.
    Catheter Cardiovasc Interv; 2012 Nov 01; 80(5):728-34. PubMed ID: 22378485
    [Abstract] [Full Text] [Related]

  • 5. Use of a percutaneous left ventricular assist device for high-risk cardiac interventions and cardiogenic shock.
    Thomas JL, Al-Ameri H, Economides C, Shareghi S, Abad DG, Mayeda G, Burstein S, Shavelle DM.
    J Invasive Cardiol; 2010 Aug 01; 22(8):360-4. PubMed ID: 20679671
    [Abstract] [Full Text] [Related]

  • 6. Assisted circulation using the TandemHeart during very high-risk PCI of the unprotected left main coronary artery in patients declined for CABG.
    Vranckx P, Schultz CJ, Valgimigli M, Eindhoven JA, Kappetein AP, Regar ES, Van Domburg R, Serruys PW.
    Catheter Cardiovasc Interv; 2009 Aug 01; 74(2):302-10. PubMed ID: 19360865
    [Abstract] [Full Text] [Related]

  • 7. Clinical application of prophylactic percutaneous left ventricular assist device (TandemHeart) in high-risk percutaneous coronary intervention using an arterial preclosure technique: single-center experience.
    Rajdev S, Krishnan P, Irani A, Kim MC, Moreno PR, Sharma SK, Kini AS.
    J Invasive Cardiol; 2008 Feb 01; 20(2):67-72. PubMed ID: 18252970
    [Abstract] [Full Text] [Related]

  • 8. Percutaneous left ventricular assist device: "TandemHeart" for high-risk coronary intervention.
    Aragon J, Lee MS, Kar S, Makkar RR.
    Catheter Cardiovasc Interv; 2005 Jul 01; 65(3):346-52. PubMed ID: 15945107
    [Abstract] [Full Text] [Related]

  • 9. Clinical experience and patient outcomes associated with the TandemHeart percutaneous transseptal assist device among a heterogeneous patient population.
    Tempelhof MW, Klein L, Cotts WG, Benzuly KH, Davidson CJ, Meyers SN, McCarthy PM, Malaisrie CS, McGee EC, Beohar N.
    ASAIO J; 2011 Jul 01; 57(4):254-61. PubMed ID: 21546824
    [Abstract] [Full Text] [Related]

  • 10. Percutaneous left ventricular assist device, TandemHeart, for high-risk percutaneous coronary revascularization. A single centre experience.
    Giombolini C, Notaristefano S, Santucci S, Fortunati F, Savino K, Sindaco FD, Ragni T, Allegri M, Ambrosio G.
    Acute Card Care; 2006 Jul 01; 8(1):35-40. PubMed ID: 16720426
    [Abstract] [Full Text] [Related]

  • 11. High-risk percutaneous coronary intervention with the TandemHeart and Impella devices: a single-center experience.
    Schwartz BG, Ludeman DJ, Mayeda GS, Kloner RA, Economides C, Burstein S.
    J Invasive Cardiol; 2011 Oct 01; 23(10):417-24. PubMed ID: 21972160
    [Abstract] [Full Text] [Related]

  • 12. Outcomes of nonemergent percutaneous coronary intervention requiring mechanical circulatory support in patients without cardiogenic shock.
    Al-Khadra Y, Alraies MC, Darmoch F, Pacha HM, Soud M, Kaki A, Rab T, Grines CL, Meraj P, Alaswad K, Kwok CS, Mamas M, Kapadia S.
    Catheter Cardiovasc Interv; 2020 Feb 15; 95(3):503-512. PubMed ID: 31254325
    [Abstract] [Full Text] [Related]

  • 13. Hemodynamic support with a percutaneous left ventricular assist device during stenting of an unprotected left main coronary artery.
    Kar B, Butkevich A, Civitello AB, Nawar MA, Walton B, Messner GN, Gregoric ID, Feldman J, Myers TJ, Gemmato C, Delgado RM.
    Tex Heart Inst J; 2004 Feb 15; 31(1):84-6. PubMed ID: 15061632
    [Abstract] [Full Text] [Related]

  • 14. Trends in the Outcomes of High-risk Percutaneous Ventricular Assist Device-assisted Percutaneous Coronary Intervention, 2008-2018.
    Lemor A, Basir MB, Truesdell AG, Tamis-Holland JE, Alqarqaz M, Grines CL, Villablanca PA, Alaswad K, Pinto DS, O'Neill W.
    Am J Cardiol; 2021 Oct 01; 156():65-71. PubMed ID: 34344515
    [Abstract] [Full Text] [Related]

  • 15. Hemodynamically supported percutaneous coronary revascularization improves left ventricular function in patients with ischemic dilated cardiomyopathy at very high risk for surgery: a single-center experience.
    Gimelli G, Wolff MR.
    J Invasive Cardiol; 2008 Dec 01; 20(12):642-6. PubMed ID: 19057027
    [Abstract] [Full Text] [Related]

  • 16. Prophylactic use of intra-aortic balloon pump for high-risk percutaneous coronary intervention: will the Impella LP 2.5 device show superiority in a clinical randomized study?
    Syed AI, Kakkar A, Torguson R, Li Y, Ben-Dor I, Collins SD, Lemesle G, Maluenda G, Xue Z, Scheinowitz M, Kaneshige K, Satler LF, Kent KM, Suddath WO, Pichard AD, Lindsay J, Waksman R.
    Cardiovasc Revasc Med; 2010 Dec 01; 11(2):91-7. PubMed ID: 20347798
    [Abstract] [Full Text] [Related]

  • 17. Percutaneous ventricular assist device for higher-risk percutaneous coronary intervention in surgically ineligible patients: Indications and outcomes from the OPTIMUM study.
    Hirai T, Grantham JA, Kandzari DE, Ballard W, Brown WM, Allen KB, Kirtane AJ, Argenziano M, Yeh RW, Khabbaz K, Lombardi W, Lasala J, Kachroo P, Karmpaliotis D, Gosch KL, Salisbury AC, OPTIMUM Study Group.
    Catheter Cardiovasc Interv; 2023 Nov 01; 102(5):814-822. PubMed ID: 37676058
    [Abstract] [Full Text] [Related]

  • 18. Outcomes of bailout percutaneous ventricular assist device versus prophylactic strategy in patients undergoing nonemergent percutaneous coronary intervention.
    O'Neill BP, Grines C, Moses JW, Ohman EM, Lansky A, Popma J, Kapur NK, Schreiber T, Mannino S, O'Neill WW, Medjamia AM, Mahmud E.
    Catheter Cardiovasc Interv; 2021 Oct 01; 98(4):E501-E512. PubMed ID: 34051033
    [Abstract] [Full Text] [Related]

  • 19. Use of the Impella 2.5 for prophylactic circulatory support during elective high-risk percutaneous coronary intervention.
    Alasnag MA, Gardi DO, Elder M, Kannam H, Ali F, Petrina M, Kheterpal V, Hout MS, Schreiber TL.
    Cardiovasc Revasc Med; 2011 Oct 01; 12(5):299-303. PubMed ID: 21454139
    [Abstract] [Full Text] [Related]

  • 20. The Bypass Angioplasty Revascularization in Type 1 and Type 2 Diabetes Study: 5-year follow-up of revascularization with percutaneous coronary intervention versus coronary artery bypass grafting in diabetic patients with multivessel disease.
    Kapur A, Bartolini D, Finlay MC, Qureshi AC, Flather M, Strange JW, Hall RJ.
    J Cardiovasc Med (Hagerstown); 2010 Jan 01; 11(1):26-33. PubMed ID: 19797974
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.